- Home
- TARS vs ERO Comparison
TARS vs ERO Comparison
Compare TARS & ERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TARS | ERO |
|---|---|---|
| Founded | 2016 | 2016 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 3.2B |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | TARS | ERO |
|---|---|---|
| Price | $65.11 | $31.12 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 2 |
| Target Price | ★ $89.00 | $36.50 |
| AVG Volume (30 Days) | 595.9K | ★ 1.1M |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 48.21 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $451,360,000.00 | N/A |
| Revenue This Year | $56.43 | $51.94 |
| Revenue Next Year | $30.19 | $2.43 |
| P/E Ratio | ★ N/A | $22.61 |
| Revenue Growth | ★ 146.71 | N/A |
| 52 Week Low | $38.51 | $12.79 |
| 52 Week High | $85.25 | $39.80 |
Technical Indicators
Market Signals| Indicator | TARS | ERO |
|---|---|---|
| Relative Strength Index (RSI) | 51.22 | 63.58 |
| Support Level | $61.24 | $27.82 |
| Resistance Level | $67.24 | $32.48 |
| Average True Range (ATR) | 3.59 | 1.36 |
| MACD | 0.09 | 0.59 |
| Stochastic Oscillator | 81.30 | 80.41 |
Price Performance
Historical ComparisonAbout TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.
About ERO Ero Copper Corp.
Ero Copper Corp is a base metals mining company. It is predominantly focused on the production and sale of copper with gold and silver produced and sold as by-products. Ero's operations are segmented between its mines in Brazil, the Caraiba Operations and the Xavantina Operations, its development project, the Tucuma Project in Brazil and corporate. Majority of its revenue is generated from its Caraiba Operations segment which consists of mining operations and processing facilities including the Pilar and Vermelhos underground mines and the Surubim open pit mine.